Literature DB >> 17299069

Circulating preprandial ghrelin to obestatin ratio is increased in human obesity.

Zhi-Fu Guo1, Xing Zheng, Yong-Wen Qin, Jian-Qiang Hu, Shao-Ping Chen, Zheng Zhang.   

Abstract

CONTEXT: Obestatin, a sibling of ghrelin derived from preproghrelin, opposes ghrelin's effects on food intake. Plasma obestatin profiles in relation to ghrelin have not been fully investigated in human obesity.
OBJECTIVE: We hypothesize that obesity might present with imbalance of circulating ghrelin and obestatin levels. PARTICIPANTS AND
SETTING: Sixteen obese (eight men, aged 58.8 +/- 4.9 yr; eight women, aged 59.9 +/- 9.6 yr) and 14 normal-weight individuals (seven men, aged 52.7 +/- 5.9 yr; seven women, aged 56.1 +/- 4.9 yr) were evaluated at the in-patient department of Changhai Hospital, Shanghai, China. MAIN OUTCOME MEASURES: Total plasma ghrelin and obestatin levels, 1 h before and 2 h after breakfast, were measured by RIA.
RESULTS: Both preprandial plasma ghrelin levels (P < 0.01) and obestatin levels (P < 0.01) were lower in the obese compared with normal-weight controls. However, unexpectedly, the ratio of preprandial ghrelin to obestatin was higher in obese compared with normal-weight controls (P < 0.01) even after adjustment for gender and age (P < 0.01). The ratio of postprandial ghrelin to obestatin was decreased both in obese (P < 0.05) and controls (P < 0.01) compared with their preprandial levels. There were no significant differences in the ratio of postprandial ghrelin to obestatin between obese and normal-weight controls. Body mass index was positively correlated with and was a significantly independent determinant of the preprandial ghrelin to obestatin ratio.
CONCLUSION: Circulating preprandial ghrelin to obestatin ratio is elevated in human obesity. We suggest that high preprandial ghrelin to obestatin ratio may be involved in the etiology and pathophysiology of obesity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17299069     DOI: 10.1210/jc.2006-2306

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  18 in total

1.  Circulating obestatin levels in normal and Type 2 diabetic subjects.

Authors:  D H St-Pierre; F Settanni; I Olivetti; E Gramaglia; M Tomelini; R Granata; F Prodam; A Benso; E Ghigo; F Broglio
Journal:  J Endocrinol Invest       Date:  2010-05-05       Impact factor: 4.256

Review 2.  The gut sensor as regulator of body weight.

Authors:  Thomas Reinehr; Christian L Roth
Journal:  Endocrine       Date:  2014-12-30       Impact factor: 3.633

3.  Impact of sustained weight loss achieved through Roux-en-Y gastric bypass or a lifestyle intervention on ghrelin, obestatin, and ghrelin/obestatin ratio in morbidly obese patients.

Authors:  Catia Martins; Louise Kjelstrup; Ingrid L Mostad; Bård Kulseng
Journal:  Obes Surg       Date:  2011-06       Impact factor: 4.129

4.  Acute effect of smoking on plasma Obestatin levels.

Authors:  Asterios Kukuvitis; Marios Froudarakis; Stavros Tryfon; Argyris Tzouvelekis; Maria Saroglou; Nikolaos Karkavitsas; Demosthenes Bouros
Journal:  Tob Induc Dis       Date:  2010-01-07       Impact factor: 2.600

5.  Effect of peripheral obestatin on food intake and gastric emptying in ghrelin-knockout mice.

Authors:  I Depoortere; T Thijs; D Moechars; B De Smet; L Ver Donck; T L Peeters
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

6.  Characteristics associated with fasting appetite hormones (obestatin, ghrelin, and leptin).

Authors:  Jeannette M Beasley; Brett A Ange; Cheryl A M Anderson; Edgar R Miller Iii; Janet T Holbrook; Lawrence J Appel
Journal:  Obesity (Silver Spring)       Date:  2008-12-04       Impact factor: 5.002

7.  Eradication of Helicobacter pylori increases ghrelin mRNA expression in the gastric mucosa.

Authors:  Eon Sook Lee; Yeong Sook Yoon; Cheol-Young Park; Han-Seong Kim; Tae Hyun Um; Hyun Wook Baik; Eun Jeong Jang; Sangyeoup Lee; Hee Soon Park; Sang Woo Oh
Journal:  J Korean Med Sci       Date:  2010-01-22       Impact factor: 2.153

8.  Ghrelin and obestatin levels in type 2 diabetic patients with and without delayed gastric emptying.

Authors:  Igor A Harsch; Corinna Koebnick; Atingwa M Tasi; Eckhart Georg Hahn; Peter C Konturek
Journal:  Dig Dis Sci       Date:  2008-12-11       Impact factor: 3.199

9.  Differential secretion of satiety hormones with progression of obesity in JCR:LA-corpulent rats.

Authors:  Jill A Parnell; Raylene A Reimer
Journal:  Obesity (Silver Spring)       Date:  2008-01-24       Impact factor: 5.002

10.  Ghrelin and obestatin levels in severely obese women before and after weight loss after Roux-en-Y gastric bypass surgery.

Authors:  Christian L Roth; Thomas Reinehr; Gerit-Holger Schernthaner; Hans-Peter Kopp; Stefan Kriwanek; Guntram Schernthaner
Journal:  Obes Surg       Date:  2008-06-03       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.